Patents by Inventor Bailing YANG

Bailing YANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12291530
    Abstract: The present disclosure describes GLP-1R modulating compounds that are useful for treating GLP-1R-mediated diseases or conditions.
    Type: Grant
    Filed: September 13, 2024
    Date of Patent: May 6, 2025
    Assignee: Ascletis Pharma (China) Co., Limited
    Inventors: Bin Liang, Jinzi Jason Wu, Bailing Yang
  • Patent number: 12234236
    Abstract: The present disclosure describes GLP-1R modulating compounds that are useful for treating GLP-1R-mediated diseases or conditions,
    Type: Grant
    Filed: September 13, 2024
    Date of Patent: February 25, 2025
    Assignee: Ascletis Pharma (China) Co., Limited
    Inventors: Bin Liang, Jinzi Jason Wu, Bailing Yang
  • Publication number: 20250011303
    Abstract: The present application describes compounds of IL-17A modulator that are useful for treating an IL-17A mediated inflammatory syndrome, disorder, or disease.
    Type: Application
    Filed: May 17, 2024
    Publication date: January 9, 2025
    Inventors: Bin Liang, Bailing Yang, Donghuang Liu, Jinzi Jason Wu
  • Publication number: 20240327428
    Abstract: The present application describes compounds of capsid inhibitors that are useful for treating HIV infection in a human. One aspect of the present application relates to a compound of Formula I, stereoisomers thereof, pharmaceutically acceptable salts thereof, or deuterium substitutes thereof as described in the present disclosure.
    Type: Application
    Filed: February 22, 2024
    Publication date: October 3, 2024
    Inventors: Jinzi Jason WU, Bin LIANG, Bailing YANG
  • Patent number: 12084469
    Abstract: A method for preparing the cyclic phosphonate compound of Formula I is described. The method significantly improves the stereoselectivity of the compound with the required configuration.
    Type: Grant
    Filed: June 27, 2023
    Date of Patent: September 10, 2024
    Assignee: GANNEX PHARMA CO., LTD.
    Inventors: Jinzi Jason Wu, Bailing Yang, Bin Liang
  • Publication number: 20240189337
    Abstract: Certain anti-viral compounds, pharmaceutical compositions, and methods related thereto are disclosed.
    Type: Application
    Filed: November 27, 2023
    Publication date: June 13, 2024
    Inventors: Bin LIANG, Bailing YANG, Yang LAI, Jinzi Jason WU
  • Patent number: 11865132
    Abstract: Certain anti-viral compounds, pharmaceutical compositions, and methods related thereto are disclosed.
    Type: Grant
    Filed: October 13, 2022
    Date of Patent: January 9, 2024
    Assignee: ASCLETIS BIOSCIENCE CO., LTD.
    Inventors: Bin Liang, Bailing Yang, Yang Lai, Jinzi Jason Wu
  • Publication number: 20230339993
    Abstract: A method for preparing the cyclic phosphonate compound of Formula I is described. The method significantly improves the stereoselectivity of the compound with the required configuration.
    Type: Application
    Filed: June 27, 2023
    Publication date: October 26, 2023
    Inventors: Jinzi Jason WU, Bailing YANG, Bin LIANG
  • Patent number: 11760722
    Abstract: Certain anti-viral compounds, pharmaceutical compositions, and methods related thereto are disclosed.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: September 19, 2023
    Assignee: ASCLETIS BIOSCIENCE CO., LTD.
    Inventors: Bailing Yang, Bin Liang, Yang Lai, Jinzi J. Wu
  • Publication number: 20230271949
    Abstract: The present application describes GLP-IR modulating compounds that are useful for treating GLP-IR-mediated diseases or conditions.
    Type: Application
    Filed: November 18, 2022
    Publication date: August 31, 2023
    Inventors: Bin Liang, Yacheng Yang, Peng Wang, Bailing Yang, Yang Lai, Jinzi J. Wu
  • Patent number: 11725019
    Abstract: A method for preparing the cyclic phosphonate compound of Formula I is described. The method significantly improves the stereoselectivity of the compound with the required configuration.
    Type: Grant
    Filed: March 3, 2022
    Date of Patent: August 15, 2023
    Assignee: GANNEX PHARMA CO LTD.
    Inventors: Jinzi J. Wu, Bailing Yang, Bin Liang
  • Publication number: 20230234921
    Abstract: Certain anti-viral compounds, pharmaceutical compositions, and methods related thereto are disclosed.
    Type: Application
    Filed: March 28, 2023
    Publication date: July 27, 2023
    Inventors: Bailing YANG, Bin LIANG, Yang LAI, Jinzi Jason WU
  • Publication number: 20230190782
    Abstract: Certain anti-viral compounds, pharmaceutical compositions, and methods related thereto are disclosed.
    Type: Application
    Filed: October 13, 2022
    Publication date: June 22, 2023
    Inventors: Bin LIANG, Bailing Yang, Yang Lai, Jinzi Jason Wu
  • Publication number: 20230165843
    Abstract: Provided are a method of treating or preventing infection with hepatitis B virus in a human or animal, comprising administering to the human or animal in need thereof a therapeutically effective amount of a phenylisoxazolyl methylene-naphthalene-ether derivative having a structure of formula (I); use of a phenylisoxazolyl methylene-naphthalene-ether derivative having a structure of formula (I) in the preparation of a pharmaceutical composition for anti-hepatitis B vims and a pharmaceutical composition for anti-hepatitis B virus.
    Type: Application
    Filed: October 12, 2020
    Publication date: June 1, 2023
    Inventors: Bailing YANG, Gudmundsson KRISTJAN, Liuyu DONG, James CHEN
  • Publication number: 20230159451
    Abstract: Certain anti-viral compounds, pharmaceutical compositions, and methods related thereto are disclosed.
    Type: Application
    Filed: June 10, 2022
    Publication date: May 25, 2023
    Inventors: Bailing YANG, Bin LIANG, Yang LAI, Jinzi J. WU
  • Patent number: 11541071
    Abstract: Certain anti-viral compounds, pharmaceutical compositions, and methods related thereto are disclosed.
    Type: Grant
    Filed: May 20, 2022
    Date of Patent: January 3, 2023
    Assignee: Ascletis BioScience Co., Ltd
    Inventors: Bin Liang, Bailing Yang, Yang Lai, Jinzi Jason Wu
  • Publication number: 20220388997
    Abstract: Provided are a compound for modulating the activity of FXR having a structure of formula (I), a pharmaceutically acceptable salt, an ester or a stereoisomer thereof.
    Type: Application
    Filed: October 12, 2020
    Publication date: December 8, 2022
    Inventors: Bailing YANG, Gudmundsson KRISTJAN, Liuyu DONG, James CHEN
  • Publication number: 20220332738
    Abstract: A method for preparing the cyclic phosphonate compound of Formula I is described. The method significantly improves the stereoselectivity of the compound with the required configuration.
    Type: Application
    Filed: March 3, 2022
    Publication date: October 20, 2022
    Inventors: Jinzi J. WU, Bailing YANG, Bin LIANG
  • Patent number: 11292805
    Abstract: A method for preparing the cyclic phosphonate compound of Formula I is described. The method significantly improves the stereoselectivity of the compound with the required configuration.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: April 5, 2022
    Assignee: GANNEX PHARMA CO., LTD.
    Inventors: Jinzi Jason Wu, Bailing Yang, Bin Liang
  • Publication number: 20210277039
    Abstract: A method for preparing the cyclic phosphonate compound of Formula I is described. The method significantly improves the stereoselectivity of the compound with the required configuration.
    Type: Application
    Filed: April 15, 2021
    Publication date: September 9, 2021
    Inventors: Jinzi Jason WU, Bailing YANG, Bin LIANG